Abstract
In recent years, with the development of molecular biology, the exploration and development of targeted drugs for cancer has gradually attracted widespread attention. Here, tumor-targeted astaxanthin nanoparticle, cRGD-PEG2000-DSPE encapsulated astaxanthin (cRGD@AST) was designed and applied for tumor therapy. Firstly, cRGD@AST can improve the water solubility of astaxanthin. Secondly, cRGD@AST can achieve tumor-targeted ability after cRGD modification and can be highly absorbed by HepG2 cells. Finally, cRGD@AST can scavenge excess ROS in tumor cells, restore the redox balance in cells, and inhibit tumor cell proliferation. It provides theoretical basis and experimental basis for the development and utilization of natural product antioxidants for cancer prevention and treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
